Micro RNA-148A as a Biomarker for Advanced Colorectal Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130164279A1
SERIAL NO

13708537

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention includes methods of detection, diagnosis, prognosis, and treatment of a patient suspected of having a colorectal cancer comprising obtaining one or more samples of the patient, determining a level of expression of miR-148a or the level of methylation of a miR-148a promoter, and predicting a response to a cytotoxic chemotherapy cancer treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYLOR RESEARCH INSTITUTE3434 LIVE OAK STREET DALLAS TX 75204

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boland, C Richard Dallas, US 15 106
Goel, Ajay Dallas, US 21 89
Takahashi, Masanobu Richardson, US 45 384

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation